What Is PSA? Ranges, Units and Velocity on Testosterone (TRT)

What PSA actually measures

Prostate-specific antigen is an enzyme that liquefies semen. A small amount leaks into the bloodstream, and the lab reports that concentration in ng/mL. It is "prostate-specific" but not "cancer-specific": benign prostatic enlargement, a recent infection, vigorous cycling, ejaculation, or a digital rectal exam can all raise the number temporarily. That is why a single reading is interpreted as a trend, not a verdict, and why the rate of change matters as much as the value itself (StatPearls, 2024).

On Testosterone (TRT) the concern is biological. Testosterone is converted in prostate tissue to dihydrotestosterone, which drives prostate growth, so restoring testosterone from a low baseline can nudge PSA upward in the first months. The Endocrine Society guideline recommends checking PSA and doing a prostate assessment before starting therapy in men over 40 with a baseline above 0.6 ng/mL, then re-checking at 3 to 12 months and annually thereafter (Bhasin 2018). The point is to catch an abnormal trajectory early, not to ban testosterone.

Typical PSA ranges and what triggers review

There is no single "normal" PSA because the threshold drifts upward with age as the prostate enlarges. The age-banded 95th-percentile cut-offs below are widely used; values above the band, or a fast rise within a band, are what prompt a closer look.

These bands are reference ranges, not personal targets. A 52-year-old sitting at 1.2 ng/mL and a 52-year-old at 3.4 ng/mL are both "in range," yet the second man's higher baseline means a smaller absolute rise will cross his threshold. That is exactly why velocity, the speed of change, is tracked separately.

How PSA velocity is calculated

PSA velocity is the change in PSA divided by the time between tests. The arithmetic is deliberately simple so you can sanity-check what a clinic reports:

PSA velocity (ng/mL/yr) = (later PSA − earlier PSA) ÷ years elapsed

Percent change is the companion figure: % change = (later − earlier) ÷ earlier × 100. A commonly cited concern threshold is a velocity above roughly 0.75 ng/mL/yr when measured across three readings over at least 18 months, or any confirmed rise above about 1.4 ng/mL inside the first year of Testosterone (TRT) (StatPearls 2024; Bhasin 2018). For best accuracy, use the same lab and assay each time, because PSA methods vary between machines.

Two readings give you a rough slope; three readings spaced over 18 months smooth out the day-to-day noise from infections, exercise, or ejaculation. The worked examples below show the same formula applied to different timelines and baselines.

Worked examples

How this is calculated

Every figure above uses two operations only. Velocity divides the PSA difference by the elapsed time in years (so a 6-month gap uses 0.5, a 3-month gap uses 0.25). Percent change divides the difference by the starting value and multiplies by 100. Nothing here adjusts the dose: PSA does not feed your injection volume, which depends on prescribed milligrams and vial concentration in mg/mL. If you want to model that side, the Testosterone (TRT) dose calculator turns mg per week and mg/mL into a syringe draw. PSA stays a monitoring number you plot over time, ideally from the same lab to keep the assay constant.

Common misreadings

The first mistake is reacting to one high reading. PSA bounces with infection, ejaculation, exercise, and exam timing, so a single value above range is confirmed with a repeat test before any decision. The second is comparing results from different labs, since assays are not perfectly interchangeable and can shift the number by a few tenths. The third is treating the age band as a personal target; a 0.5 ng/mL rise means something different at a baseline of 1.0 than at 3.6.

Because PSA touches cancer screening, this is firmly a clinician's call. InjectBuddy gives you the arithmetic to follow your own trend and ask better questions; it does not interpret results or replace urological assessment.

So, what is PSA?

PSA (prostate-specific antigen) is a protein produced by prostate tissue and reported in nanograms per milliliter (ng/mL). On TRT it is monitored because testosterone can stimulate the prostate, so clinicians watch both the absolute level and its rate of change — PSA velocity, calculated as (later PSA minus earlier PSA) divided by the years between tests. A confirmed baseline above 4 ng/mL or a first-year rise above roughly 1.4 ng/mL typically prompts a urological review. To work out your actual testosterone injection dose and draw volume, use the Testosterone (TRT) dose calculator.

FAQs